Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptides

By Hioe C.E.   Qiu H.   Chend P.-D.   Bian Z.   Ming-Lie L.   Li J.   Singh M.   Kuebler P.   McGee P.   O'Hagan D.   Zamb T.   Koff W.   Allsopp C.   Chang Y.W.   Nixon D.F.  

Vaccine, Vol. 14, Iss. 5, 1996-04 ,pp. : 412-418

Elsevier

Access to resources Recommend Favorite

Flt3 ligand and conjugation to IL-1 peptide as adjuvants for a type 1, T-cell response to an HIV p17 gag vaccine

By Pisarev V.M.   Parajuli P.   Mosley R.L.   Chavez J.   Zimmerman D.   Winship D.   Talmadge J.E.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2358-2368

Elsevier

Access to resources Recommend Favorite

Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity

By Nixon D.F.   Hioe C.   Pei-de C.   Zuning B.   Kuebler P.   Ming-Lie L.   Qiu H.   Xuan-Mao L.   Singh M.   Richardson J.   McGee P.   Zamb T.   Koff W.   Chang Y.W.   O'Hagan D.  

Vaccine, Vol. 14, Iss. 16, 1996-11 ,pp. : 1523-1530

Elsevier

Access to resources Recommend Favorite

Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate cancer vaccines

By Kim S.K.   Ragupathi G.   Musselli C.   Choi S.-J.   Park Y.S.   Livingston P.O.  

Vaccine, Vol. 18, Iss. 7, 1999-11 ,pp. : 597-603

Elsevier

Access to resources Recommend Favorite

The N-terminal 303 amino acids of the human cytomegalovirus envelope glycoprotein B (UL55) and the exon 4 region of the major immediate early protein 1 (UL123) induce a cytotoxic T-cell response

By Berencsi K.   Gonczol E.   Endresz V.   Kough J.   Takeda S.   Gyulay Z.   Plotkin S.A.   Rando R.F.  

Vaccine, Vol. 14, Iss. 5, 1996-04 ,pp. : 369-374

Elsevier

Access to resources Recommend Favorite